CHAPTER 1:INTRODUCTION
1.1.Report description
1.2.Key market segments
1.3.Key benefits to the stakeholders
1.4.Research Methodology
1.4.1.Secondary research
1.4.2.Primary research
1.4.3.Analyst tools and models
CHAPTER 2:EXECUTIVE SUMMARY
2.1.Key findings of the study
2.2.CXO Perspective
CHAPTER 3:MARKET OVERVIEW
3.1.Market definition and scope
3.2.Key findings
3.2.1.Top investment pockets
3.3.Porter’s five forces analysis
3.4.Top player positioning
3.5.Market dynamics
3.5.1.Drivers
3.5.2.Restraints
3.5.3.Opportunities
3.6.COVID-19 Impact Analysis on the market
CHAPTER 4: CELL LINE AND MEMBRANE MARKET, BY PRODUCTS
4.1 Overview
4.1.1 Market size and forecast
4.2 Media and Reagents
4.2.1 Key market trends, growth factors and opportunities
4.2.2 Market size and forecast, by region
4.2.3 Market analysis by country
4.2.4 Media and Reagents Cell Line and Membrane Market by Type
4.2.4.1 Serum Market size and forecast, by region
4.2.4.2 Media Market size and forecast, by region
4.2.4.3 Reagents Market size and forecast, by region
4.3 Equipments
4.3.1 Key market trends, growth factors and opportunities
4.3.2 Market size and forecast, by region
4.3.3 Market analysis by country
4.3.4 Equipments Cell Line and Membrane Market by Type
4.3.4.1 Biosafety Cabinets Market size and forecast, by region
4.3.4.2 Cell Counters and Viability Systems Market size and forecast, by region
4.3.4.3 Incubators Market size and forecast, by region
4.3.4.4 Centrifuges Market size and forecast, by region
4.3.4.5 Bioreactors Market size and forecast, by region
4.3.4.6 Storage Equipment Market size and forecast, by region
4.3.4.7 Others Market size and forecast, by region
4.4 Accessories and Consumables
4.4.1 Key market trends, growth factors and opportunities
4.4.2 Market size and forecast, by region
4.4.3 Market analysis by country
CHAPTER 5: CELL LINE AND MEMBRANE MARKET, BY SOURCE
5.1 Overview
5.1.1 Market size and forecast
5.2 Non Mammalian Cell Line
5.2.1 Key market trends, growth factors and opportunities
5.2.2 Market size and forecast, by region
5.2.3 Market analysis by country
5.2.4 Non Mammalian Cell Line Cell Line and Membrane Market by Type
5.2.4.1 Insects Market size and forecast, by region
5.2.4.2 Amphibians Market size and forecast, by region
5.3 Mammalian Cell Line
5.3.1 Key market trends, growth factors and opportunities
5.3.2 Market size and forecast, by region
5.3.3 Market analysis by country
CHAPTER 6: CELL LINE AND MEMBRANE MARKET, BY TYPE
6.1 Overview
6.1.1 Market size and forecast
6.2 Recombinant cell lines
6.2.1 Key market trends, growth factors and opportunities
6.2.2 Market size and forecast, by region
6.2.3 Market analysis by country
6.3 Primary cell lines
6.3.1 Key market trends, growth factors and opportunities
6.3.2 Market size and forecast, by region
6.3.3 Market analysis by country
6.4 Hybridomas
6.4.1 Key market trends, growth factors and opportunities
6.4.2 Market size and forecast, by region
6.4.3 Market analysis by country
6.5 Continuous cell lines
6.5.1 Key market trends, growth factors and opportunities
6.5.2 Market size and forecast, by region
6.5.3 Market analysis by country
CHAPTER 7: CELL LINE AND MEMBRANE MARKET, BY END USER
7.1 Overview
7.1.1 Market size and forecast
7.2 Biotechnology and Pharmaceutical Industries
7.2.1 Key market trends, growth factors and opportunities
7.2.2 Market size and forecast, by region
7.2.3 Market analysis by country
7.3 Academic and Research Institutes
7.3.1 Key market trends, growth factors and opportunities
7.3.2 Market size and forecast, by region
7.3.3 Market analysis by country
7.4 Others
7.4.1 Key market trends, growth factors and opportunities
7.4.2 Market size and forecast, by region
7.4.3 Market analysis by country
CHAPTER 8: CELL LINE AND MEMBRANE MARKET, BY REGION
8.1 Overview
8.1.1 Market size and forecast
8.2 North America
8.2.1 Key trends and opportunities
8.2.2 North America Market size and forecast, by Products
8.2.2.1 North America Media and Reagents Cell Line and Membrane Market by Type
8.2.2.2 North America Equipments Cell Line and Membrane Market by Type
8.2.3 North America Market size and forecast, by Source
8.2.3.1 North America Non Mammalian Cell Line Cell Line and Membrane Market by Type
8.2.4 North America Market size and forecast, by Type
8.2.5 North America Market size and forecast, by End User
8.2.6 North America Market size and forecast, by country
8.2.6.1 U.S.
8.2.6.1.1 Market size and forecast, by Products
8.2.6.1.2 Market size and forecast, by Source
8.2.6.1.3 Market size and forecast, by Type
8.2.6.1.4 Market size and forecast, by End User
8.2.6.2 Canada
8.2.6.2.1 Market size and forecast, by Products
8.2.6.2.2 Market size and forecast, by Source
8.2.6.2.3 Market size and forecast, by Type
8.2.6.2.4 Market size and forecast, by End User
8.2.6.3 Mexico
8.2.6.3.1 Market size and forecast, by Products
8.2.6.3.2 Market size and forecast, by Source
8.2.6.3.3 Market size and forecast, by Type
8.2.6.3.4 Market size and forecast, by End User
8.3 Europe
8.3.1 Key trends and opportunities
8.3.2 Europe Market size and forecast, by Products
8.3.2.1 Europe Media and Reagents Cell Line and Membrane Market by Type
8.3.2.2 Europe Equipments Cell Line and Membrane Market by Type
8.3.3 Europe Market size and forecast, by Source
8.3.3.1 Europe Non Mammalian Cell Line Cell Line and Membrane Market by Type
8.3.4 Europe Market size and forecast, by Type
8.3.5 Europe Market size and forecast, by End User
8.3.6 Europe Market size and forecast, by country
8.3.6.1 Germany
8.3.6.1.1 Market size and forecast, by Products
8.3.6.1.2 Market size and forecast, by Source
8.3.6.1.3 Market size and forecast, by Type
8.3.6.1.4 Market size and forecast, by End User
8.3.6.2 France
8.3.6.2.1 Market size and forecast, by Products
8.3.6.2.2 Market size and forecast, by Source
8.3.6.2.3 Market size and forecast, by Type
8.3.6.2.4 Market size and forecast, by End User
8.3.6.3 UK
8.3.6.3.1 Market size and forecast, by Products
8.3.6.3.2 Market size and forecast, by Source
8.3.6.3.3 Market size and forecast, by Type
8.3.6.3.4 Market size and forecast, by End User
8.3.6.4 Italy
8.3.6.4.1 Market size and forecast, by Products
8.3.6.4.2 Market size and forecast, by Source
8.3.6.4.3 Market size and forecast, by Type
8.3.6.4.4 Market size and forecast, by End User
8.3.6.5 Spain
8.3.6.5.1 Market size and forecast, by Products
8.3.6.5.2 Market size and forecast, by Source
8.3.6.5.3 Market size and forecast, by Type
8.3.6.5.4 Market size and forecast, by End User
8.3.6.6 Rest of Europe
8.3.6.6.1 Market size and forecast, by Products
8.3.6.6.2 Market size and forecast, by Source
8.3.6.6.3 Market size and forecast, by Type
8.3.6.6.4 Market size and forecast, by End User
8.4 Asia-Pacific
8.4.1 Key trends and opportunities
8.4.2 Asia-Pacific Market size and forecast, by Products
8.4.2.1 Asia-Pacific Media and Reagents Cell Line and Membrane Market by Type
8.4.2.2 Asia-Pacific Equipments Cell Line and Membrane Market by Type
8.4.3 Asia-Pacific Market size and forecast, by Source
8.4.3.1 Asia-Pacific Non Mammalian Cell Line Cell Line and Membrane Market by Type
8.4.4 Asia-Pacific Market size and forecast, by Type
8.4.5 Asia-Pacific Market size and forecast, by End User
8.4.6 Asia-Pacific Market size and forecast, by country
8.4.6.1 Japan
8.4.6.1.1 Market size and forecast, by Products
8.4.6.1.2 Market size and forecast, by Source
8.4.6.1.3 Market size and forecast, by Type
8.4.6.1.4 Market size and forecast, by End User
8.4.6.2 China
8.4.6.2.1 Market size and forecast, by Products
8.4.6.2.2 Market size and forecast, by Source
8.4.6.2.3 Market size and forecast, by Type
8.4.6.2.4 Market size and forecast, by End User
8.4.6.3 Australia
8.4.6.3.1 Market size and forecast, by Products
8.4.6.3.2 Market size and forecast, by Source
8.4.6.3.3 Market size and forecast, by Type
8.4.6.3.4 Market size and forecast, by End User
8.4.6.4 India
8.4.6.4.1 Market size and forecast, by Products
8.4.6.4.2 Market size and forecast, by Source
8.4.6.4.3 Market size and forecast, by Type
8.4.6.4.4 Market size and forecast, by End User
8.4.6.5 South Korea
8.4.6.5.1 Market size and forecast, by Products
8.4.6.5.2 Market size and forecast, by Source
8.4.6.5.3 Market size and forecast, by Type
8.4.6.5.4 Market size and forecast, by End User
8.4.6.6 Rest of Asia-Pacific
8.4.6.6.1 Market size and forecast, by Products
8.4.6.6.2 Market size and forecast, by Source
8.4.6.6.3 Market size and forecast, by Type
8.4.6.6.4 Market size and forecast, by End User
8.5 LAMEA
8.5.1 Key trends and opportunities
8.5.2 LAMEA Market size and forecast, by Products
8.5.2.1 LAMEA Media and Reagents Cell Line and Membrane Market by Type
8.5.2.2 LAMEA Equipments Cell Line and Membrane Market by Type
8.5.3 LAMEA Market size and forecast, by Source
8.5.3.1 LAMEA Non Mammalian Cell Line Cell Line and Membrane Market by Type
8.5.4 LAMEA Market size and forecast, by Type
8.5.5 LAMEA Market size and forecast, by End User
8.5.6 LAMEA Market size and forecast, by country
8.5.6.1 Brazil
8.5.6.1.1 Market size and forecast, by Products
8.5.6.1.2 Market size and forecast, by Source
8.5.6.1.3 Market size and forecast, by Type
8.5.6.1.4 Market size and forecast, by End User
8.5.6.2 Saudi Arabia
8.5.6.2.1 Market size and forecast, by Products
8.5.6.2.2 Market size and forecast, by Source
8.5.6.2.3 Market size and forecast, by Type
8.5.6.2.4 Market size and forecast, by End User
8.5.6.3 South Africa
8.5.6.3.1 Market size and forecast, by Products
8.5.6.3.2 Market size and forecast, by Source
8.5.6.3.3 Market size and forecast, by Type
8.5.6.3.4 Market size and forecast, by End User
8.5.6.4 Rest of LAMEA
8.5.6.4.1 Market size and forecast, by Products
8.5.6.4.2 Market size and forecast, by Source
8.5.6.4.3 Market size and forecast, by Type
8.5.6.4.4 Market size and forecast, by End User
CHAPTER 9: COMPANY LANDSCAPE
9.1. Introduction
9.2. Top winning strategies
9.3. Product Mapping of Top 10 Player
9.4. Competitive Dashboard
9.5. Competitive Heatmap
9.6. Key developments
CHAPTER 10: COMPANY PROFILES
10.1 Advanced Instruments LLC
10.1.1 Company overview
10.1.2 Company snapshot
10.1.3 Operating business segments
10.1.4 Product portfolio
10.1.5 Business performance
10.1.6 Key strategic moves and developments
10.2 AGC Biologics
10.2.1 Company overview
10.2.2 Company snapshot
10.2.3 Operating business segments
10.2.4 Product portfolio
10.2.5 Business performance
10.2.6 Key strategic moves and developments
10.3 Cytiva Lifesciences
10.3.1 Company overview
10.3.2 Company snapshot
10.3.3 Operating business segments
10.3.4 Product portfolio
10.3.5 Business performance
10.3.6 Key strategic moves and developments
10.4 Sartorius
10.4.1 Company overview
10.4.2 Company snapshot
10.4.3 Operating business segments
10.4.4 Product portfolio
10.4.5 Business performance
10.4.6 Key strategic moves and developments
10.5 Cellgenix Gmbh
10.5.1 Company overview
10.5.2 Company snapshot
10.5.3 Operating business segments
10.5.4 Product portfolio
10.5.5 Business performance
10.5.6 Key strategic moves and developments
10.6 Premas Biotech
10.6.1 Company overview
10.6.2 Company snapshot
10.6.3 Operating business segments
10.6.4 Product portfolio
10.6.5 Business performance
10.6.6 Key strategic moves and developments
10.7 Selexis SA
10.7.1 Company overview
10.7.2 Company snapshot
10.7.3 Operating business segments
10.7.4 Product portfolio
10.7.5 Business performance
10.7.6 Key strategic moves and developments
10.8 Samsung Biologics
10.8.1 Company overview
10.8.2 Company snapshot
10.8.3 Operating business segments
10.8.4 Product portfolio
10.8.5 Business performance
10.8.6 Key strategic moves and developments
10.9 Lonza
10.9.1 Company overview
10.9.2 Company snapshot
10.9.3 Operating business segments
10.9.4 Product portfolio
10.9.5 Business performance
10.9.6 Key strategic moves and developments
10.10 Thermofisher Scientific Inc
10.10.1 Company overview
10.10.2 Company snapshot
10.10.3 Operating business segments
10.10.4 Product portfolio
10.10.5 Business performance
10.10.6 Key strategic moves and developments
10.11 PromoCell
10.11.1 Company overview
10.11.2 Company snapshot
10.11.3 Operating business segments
10.11.4 Product portfolio
10.11.5 Business performance
10.11.6 Key strategic moves and developments
10.12 ProBioGen
10.12.1 Company overview
10.12.2 Company snapshot
10.12.3 Operating business segments
10.12.4 Product portfolio
10.12.5 Business performance
10.12.6 Key strategic moves and developments
世界の細胞株＆膜市場2020年-2030年：製品別（培地＆試薬、機器、付属品＆消耗品）、ソース別、種類別、エンドユーザー別 |
| 【英語タイトル】Cell Line and Membrane Market By Products (Media and Reagents, Equipments, Accessories and Consumables), By Source (Non Mammalian Cell Line, Mammalian Cell Line), By Type (Recombinant cell lines, Primary cell lines, Hybridomas, Continuous cell lines), By End User (Biotechnology and Pharmaceutical Industries, Academic and Research Institutes, Others): Global Opportunity Analysis and Industry Forecast, 2021-2031 | |
 | ・商品コード：ALD23JN087 ・発行会社（調査会社）：Allied Market Research ・発行日：2022年9月 ・ページ数：346 ・レポート言語：英語 ・レポート形式：PDF ・納品方法：Eメール（受注後24時間以内） ・調査対象地域：グローバル ・産業分野：生命科学 |
| Online Only（1名閲覧、印刷不可） | USD3,570 ⇒換算￥542,640 | 見積依頼/購入/質問フォーム |
| Single User（1名閲覧） | USD5,730 ⇒換算￥870,960 | 見積依頼/購入/質問フォーム |
| Enterprise User（閲覧人数無制限） | USD9,600 ⇒換算￥1,459,200 | 見積依頼/購入/質問フォーム |
|
※販売価格オプションの説明 ※お支払金額：換算金額（日本円）＋消費税 ※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡） ※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能） |
| Allied Market Research社の本調査レポートでは、2021年に4,533.04百万ドルであった世界の細胞株＆膜市場規模が2031年には10,574.56百万ドルに達し、2022年から2031年にかけて年平均8.8％成長すると予測しています。Allied Market Research社の本調査レポートでは、世界の細胞株＆膜市場について総合的に調査・分析し、イントロダクション、エグゼクティブサマリー、市場概要、製品別（培地＆試薬、機器、付属品＆消耗品）分析、ソース別（非哺乳類細胞株、哺乳類細胞株）分析、種類別（組換え細胞株、初代細胞株、ハイブリドーマ、連続細胞株）分析、エンドユーザー別（バイオテクノロジー＆製薬産業、学術研究機関、その他）分析、地域別（北米、ヨーロッパ、アジア太平洋、中南米/中東・アフリカ）分析、企業状況、企業情報など、以下の項目でまとめています。なお、企業情報としては、Advanced Instruments LLC、AGC Biologics、Cytiva Lifesciences、Sartorius、Cellgenix Gmbh、Premas Biotech、Selexis SA、Samsung Biologics、Lonza、Thermofisher Scientific Inc、PromoCell、ProBioGenなどが含まれています。 ・イントロダクション ・エグゼクティブサマリー ・市場概要 ・世界の細胞株＆膜市場規模：製品別 - 培地＆試薬の市場規模 - 機器の市場規模 - 付属品＆消耗品の市場規模 ・世界の細胞株＆膜市場規模：ソース別 - 非哺乳類細胞株の市場規模 - 哺乳類細胞株の市場規模 ・世界の細胞株＆膜市場規模：種類別 - 組換え細胞株の市場規模 - 初代細胞株の市場規模 - ハイブリドーマの市場規模 - 連続細胞株の市場規模 ・世界の細胞株＆膜市場規模：エンドユーザー別 - バイオテクノロジー＆製薬産業における市場規模 - 学術研究機関における市場規模 - その他産業における市場規模 ・世界の細胞株＆膜市場規模：地域別 - 北米の細胞株＆膜市場規模 - ヨーロッパの細胞株＆膜市場規模 - アジア太平洋の細胞株＆膜市場規模 - 中南米/中東・アフリカの細胞株＆膜市場規模 ・企業状況 ・企業情報 |
細胞株は、与えられた適切な新鮮培地とスペースで無期限に増殖する恒久的に確立された細胞培養物であり、初代細胞の代わりに生物学的プロセスを調査するために頻繁に使用されます。トランスフェクション、選択、単一細胞クローニングはすべて細胞株作製プロセスの一部です。様々な種類の細胞を用いて、様々な細胞株が作製されます。細胞株は、管理された環境において、細胞の構造、生理、遺伝的構造を徐々に変化させることを可能にします。. 細胞株は単一細胞に由来し、融合タンパク質、モノクローナル抗体、ワクチンの製造に使用されます。
細胞株は科学研究に革命をもたらし、ワクチン製造、薬物代謝・細胞毒性試験、抗体製造、遺伝子機能研究、人工組織（人工皮膚）の作製、生物学的化合物（治療用タンパク質）の合成などに広く利用されています。
市場の成長を促進する主な要因は、癌や慢性疾患の有病率の上昇、老人人口の増加、ワクチン生産数の増加です。加えて、新薬開発活動の増加、細胞株生産のための哺乳類細胞の使用の増加、発現ベクター設計における技術的進歩の急増は、市場成長を後押しする主な要因です。例えば、国際がん研究機関によると、2020年にアジアで新たに診断されるがん患者は950万3710人。
しかし、規制の枠組みが厳しく、安定株の開発に時間がかかることが市場成長の妨げとなっています。逆に、発展途上国や低所得国における新興医療市場、パンデミックや伝染病リスクの増加は、予測期間中の市場成長に有利な機会を提供すると期待されています。
細胞株＆膜市場は、製品、ソース、種類、エンドユーザー、地域によって区分されます。
製品別では、培地＆試薬、機器、付属品＆消耗品に分類されます。
ソース別では、哺乳類細胞株と非哺乳類細胞株に二分されます。
種類別では、組換え細胞株、ハイブリドーマ、連続細胞株、初代細胞株に分類されます。
エンドユーザー別では、バイオテクノロジー企業、学術・研究機関、その他に分類されます。
地域別では、北米、欧州、アジア太平洋、LAMEAでに市場を分けて分析しています。北米は、2021年の細胞株および膜市場シェアの大半を占め、予測期間中も支配的であり続けると予測されます。アジア太平洋地域は、2021年の市場貢献度第2位であり、予測期間中、最も速いCAGRを記録すると予測されています。
細胞株＆膜市場で事業を展開する主要企業は、Advanced Instruments LLC、AGC Biologics、Cytiva Lifesciences、Sartorius Cellgenix Gmbh、Premas Biotech、Selexis SA、Lonza、Samsung Biologics、PromoCell、Thermofisher Scientific Inc、Imegenex India Pvt.Ltd.、ProBioGenです。
〈ステークホルダーにとっての主なメリット〉
・本レポートは、2021年から2031年までの細胞株＆膜市場分析の市場セグメント、現在の動向、予測、ダイナミクスを定量的に分析し、細胞株＆膜市場の市場機会を特定します。
・主要な促進要因、阻害要因、機会に関する情報とともに市場調査を提供します。
・ポーターのファイブフォース分析により、バイヤーとサプライヤーの潜在力を明らかにし、ステークホルダーが利益重視のビジネス決定を下し、サプライヤーとバイヤーのネットワークを強化できるようにします。
・細胞株＆膜市場のセグメンテーションを詳細に分析することで、市場機会を見極めることができます。
・各地域の主要国を、世界市場に対する収益貢献度に応じてマッピングしています。
・市場プレイヤーのポジショニングはベンチマーキングを容易にし、市場プレイヤーの現在のポジションを明確に理解することができます。
・地域別および世界別の細胞株＆膜市場動向、主要企業、市場セグメント、応用分野、市場成長戦略などの分析を収録しています。
主要市場セグメント
製品別
培地＆試薬
機器
付属品＆消耗品
ソース別
非哺乳動物細胞株
哺乳類細胞株
種類別
ハイブリドーマ
連続細胞株
組み換え細胞株
プライマリー細胞株
エンドユーザー別
バイオテクノロジー＆製薬産業
学術＆研究機関
その他
地域別
・北米
米国
カナダ
メキシコ
・ヨーロッパ
ドイツ
フランス
イギリス
イタリア
スペイン
その他のヨーロッパ
・アジア太平洋
日本
中国
オーストラリア
インド
韓国
その他のアジア太平洋地域
・LAMEA
ブラジル
サウジアラビア
南アフリカ
その他のLAMEA地域
〈主要市場プレイヤー〉
Advanced Instruments LLC
AGC Biologics
Cytiva Lifesciences
Sartorius
Cellgenix Gmbh
Premas Biotech
Selexis SA
Samsung Biologics
Lonza
Thermofisher Scientific Inc
PromoCell
ProBioGen
❖ レポートの目次 ❖
| ★調査レポート[世界の細胞株＆膜市場2020年-2030年：製品別（培地＆試薬、機器、付属品＆消耗品）、ソース別、種類別、エンドユーザー別] (コード：ALD23JN087)販売に関する免責事項を必ずご確認ください。 |
| ★調査レポート[世界の細胞株＆膜市場2020年-2030年：製品別（培地＆試薬、機器、付属品＆消耗品）、ソース別、種類別、エンドユーザー別]についてメールでお問い合わせ |
